The use of levamisole as an adjunct to chemotherapy and radiotherapy in the treatment of small cell carcinoma of the lung
To test the efficacy of immunotherapy in the treatment of small cell carcinoma of the lung, patients were allocated at random, in a double-blind controlled trial, to treatment with either levamisole or placebo as an adjunct to chemotherapy with multiple drugs (cyclophosphamide, vincristine, methotre...
Saved in:
Published in | Medical journal of Australia Vol. 2; no. 6; p. 285 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
17.09.1983
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | To test the efficacy of immunotherapy in the treatment of small cell carcinoma of the lung, patients were allocated at random, in a double-blind controlled trial, to treatment with either levamisole or placebo as an adjunct to chemotherapy with multiple drugs (cyclophosphamide, vincristine, methotrexate and adriamycin) and to radiotherapy. We report here the results of a pilot study of 13 patients. The median survival period of the patients who were given levamisole was 25 weeks. This was significantly shorter (P less than 0.05) than that of the patients who were given placebo (46 weeks). |
---|---|
ISSN: | 0025-729X |
DOI: | 10.5694/j.1326-5377.1983.tb122466.x |